Studies on the interaction between growth hormone and dihydroergotamine in adipose cells. I. The lipolytic effect of dihydroergotamine.
D000273:Adipose Tissue / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000324:Adrenocorticotropic Hormone / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000818:Animals; D003864:Depression, Chemical; D004357:Drug Synergism; D004822:Epididymis / Q000187:drug effects / Q000378:metabolism; D004837:Epinephrine / Q000494:pharmacology; D004878:Ergotamine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005934:Glucagon / Q000037:antagonists & inhibitors / Q000494:pharmacology; D005990:Glycerol / Q000378:metabolism; D013006:Growth Hormone / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology; D008053:Lipid Mobilization / Q000187:drug effects; D008297:Male; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic; D013268:Stimulation, Chemical; D013806:Theophylline / Q000494:pharmacology; D013972:Thyrotropin / Q000494:pharmacology; D014050:Toluene / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D011437:Propylamines; D011941:Receptors, Adrenergic; D014050:Toluene; D000324:Adrenocorticotropic Hormone; D013972:Thyrotropin; D013006:Growth Hormone; D005934:Glucagon; D011433:Propranolol; D013806:Theophylline; D005990:Glycerol; D004878:Ergotamine; D004837:Epinephrine; D010646:Phentolamine